Worst hematologic toxicity by patient
Toxicity . | ISIS 3521 . | ISIS 5132 . | ||
---|---|---|---|---|
Number of evaluable patients | 14 | 16 | ||
Median nadir (range) | ||||
ANC (×109/liter) | 2.50 (1.7–3.8) | 2.65 (1.7–4.0) | ||
WBC (×109/liter) | 4.2 (2.8–5.5) | 4.6 (2.6–5.9) | ||
Platelet (×109/liter) | 98 (9–149) | 129 (48–195) | ||
Hemoglobin (g/liter) | 109 (76–131) | 122 (80–145) | ||
Median number of days to nadir (range) | ||||
ANC | 43 (8–162) | 42 (15–83) | ||
WBC | 50 (15–162) | 29 (15–83) | ||
Platelet | 22 (14–162) | 42 (15–136) | ||
Hemoglobin | 53 (28–162) | 50 (8–92) |
Toxicity . | ISIS 3521 . | ISIS 5132 . | ||
---|---|---|---|---|
Number of evaluable patients | 14 | 16 | ||
Median nadir (range) | ||||
ANC (×109/liter) | 2.50 (1.7–3.8) | 2.65 (1.7–4.0) | ||
WBC (×109/liter) | 4.2 (2.8–5.5) | 4.6 (2.6–5.9) | ||
Platelet (×109/liter) | 98 (9–149) | 129 (48–195) | ||
Hemoglobin (g/liter) | 109 (76–131) | 122 (80–145) | ||
Median number of days to nadir (range) | ||||
ANC | 43 (8–162) | 42 (15–83) | ||
WBC | 50 (15–162) | 29 (15–83) | ||
Platelet | 22 (14–162) | 42 (15–136) | ||
Hemoglobin | 53 (28–162) | 50 (8–92) |